MedTrace Logo

Exercise and QUality Diet After Leukemia: The EQUAL Study

NCT02244411 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 358

Last updated 2025-07-22

No results posted yet for this study

Summary

The EQUAL study has been designed for adult survivors of childhood acute lymphoblastic leukemia (ALL) who are overweight or obese. The purpose of this study is to see if diet and exercise can help people lose weight and improve other health problems. This two year study will compare two methods of informing participants about ways to lose weight.

Conditions

  • Adult Survivors of Childhood Leukemia

Interventions

BEHAVIORAL

individual diet & physical activity counselor and website through Healthways at Hopkins

Phone and web-based weight loss intervention (via Healthways at Hopkins counselor and website) focused on increasing physical activity and adhering to a healthy diet. Participants will log diet, physical activity, and weight in web-hub. Counselors will have access to this information to direct participants to goals and achievements.

BEHAVIORAL

self directed weight loss

Participants will be given information and links to CDC and American Cancer Society recommendations for healthy eating and physical activity.

BEHAVIORAL

questionnaires

Participants will complete behavioral questionnaires as well as diet and physical activity assessments through CCSS-based study website as baseline, 12 and 24 months.

OTHER

fasting blood draw, measurement of height, weight and waist circumference, and blood pressure

During three time periods, at baseline and at 12 and 24 months.

Sponsors & Collaborators

Principal Investigators

  • Chaya Moskowitz, PhD · Memorial Sloan Kettering Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2025-07-16
Completion
2025-07-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02244411 on ClinicalTrials.gov